2022
DOI: 10.1253/circj.cj-21-0162
|View full text |Cite
|
Sign up to set email alerts
|

JCS/JHRS 2021 Guideline Focused Update on Non-Pharmacotherapy of Cardiac Arrhythmias

Abstract: AVNRT atrioventricular nodal reentrant tachycardia BARC Bleeding Academic Research Consortium CBA cryoballoon ablation CIED cardiac implantable electronic device COR class of recommendation CRT cardiac resynchronization therapy CRT-D cardiac resynchronization therapy defibrillator CRT-P cardiac resynchronization therapy pacemaker CT computed tomography DAP dose-area product DAPT dual antiplatelet therapy DNAR Do Not Attempt Resuscitation DOAC direct oral anticoagulant EBM evidence-based medicine ESC European S… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 38 publications
(37 citation statements)
references
References 181 publications
0
23
0
Order By: Relevance
“…The indication of left atrial appendage closure accorded with the Japanese Circulation Society guidelines [ 13 ]. Candidates were those with NVAF who had high risks of experiencing systemic embolisms, and were highly recommended to receive anti-coagulation therapy, according to the CHADS 2 score and CHA 2 DS 2 -VASc score [ 14 ].…”
Section: Methodsmentioning
confidence: 99%
“…The indication of left atrial appendage closure accorded with the Japanese Circulation Society guidelines [ 13 ]. Candidates were those with NVAF who had high risks of experiencing systemic embolisms, and were highly recommended to receive anti-coagulation therapy, according to the CHADS 2 score and CHA 2 DS 2 -VASc score [ 14 ].…”
Section: Methodsmentioning
confidence: 99%
“…The present study excluded patients with a baseline left ventricular ejection fraction (LVEF) <40%. All patients undergoing pacemaker implantation were selected according to recent guidelines (Nogami et al, 2021, 2022). Forty‐one patients (13 with HBP, 14 with RVP, and 14 controls) were included.…”
Section: Methodsmentioning
confidence: 99%
“…Among the identified patients, 368 underwent LPM implantation (Micra VR™, Medtronic, Inc, Minneapolis, Minnesota). In accordance with the Japanese guideline focused update, 9 LPM implantation was performed when venous access should be preserved or when venous occlusion or stenosis was identified. Furthermore, for patients with sinus node dysfunction (SND) and atrioventricular block (AVB), LPM implantation was considered when it was thought to be more beneficial outperforming the limitations of VVI mode, because of severe frailty and less than 1‐year survival rate, and when the LPM would be a better pacing option in patients with history of cardiac implantable electronic device infection 3 .…”
Section: Methodsmentioning
confidence: 99%